Kenney Richard T - Insider Non-Derivative Transactions at Sonnet BioTherapeutics Holdings, Inc. (SONN) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 2, 2025, Kenney Richard T's relationship to Sonnet BioTherapeutics Holdings, Inc. (SONN) is Officer (Chief Medical Officer), and currently has 163,760 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SONN insiders.

Related Topics: SEC Topic List.
Data Source: SEC.
Kenney Richard T - Insider Non-Derivative Transactions of SONN Common Stock
Kenney Richard T - Insider Non-Derivative Transactions at SONN
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Dec 3, 2025 Disposition -- (Common Stock) 69614 0 0
Dec 3, 2025 Disposition -- (Common Stock) 163760 0 0
Dec 3, 2025 Disposition -- (Common Stock) 9374 0 0
Dec 3, 2025 F -- (Common Stock) 16891 0 69614
Dec 3, 2025 M -- (Common Stock) 86505 0 86505
Dec 3, 2025 M -- (Common Stock) 163760 0 163760
Jul 12, 2025 Acquisition -- (Common Stock) 8000 0 9374
Dec 12, 2023 Acquisition -- (Common Stock) 1271 0 1374
Jan 8, 2023 Disposition -- (Common Stock) 14627 0 3571
Jan 8, 2023 Acquisition -- (Common Stock) 14627 0 18198